0
From the Guest Editors
John M. Kane, M.D.; Peter F. Buckley, M.D.; Stephen R. Marder, M.D.
CME   Schizophrenia Host Vulnerability and Risk of Metabolic Disturbances During Treatment with Antipsychotics
Peter F. Buckley, M.D.; Adriana Foster, M.D.; Brian Miller, M.D., M.P.H.
Ask the Expert: Schizophrenia
Jon Streltzer, M.D.; Wen-Shing Tseng, M.D.
Patient Management Exercise Schizophrenia
Harrison Levine, M.D., M.P.H.; Ronald C. Albucher, M.D.
New Paradigms for Treatment Development
Ellen L. Stover; Linda Brady; Stephen R. Marder
Adding or Switching Antipsychotic Medications in Treatment-Refractory Schizophrenia
Julie Kreyenbuhl, Pharm.D., Ph.D.; Steven C. Marcus, Ph.D.; Joyce C. West, Ph.D., M.P.P.; Joshua Wilk, Ph.D.; Mark Olfson, M.D., M.P.H.
Deconstructing Schizophrenia: An Overview of the Use of Endophenotypes in Order to Understand a Complex Disorder
David L. Braff; Robert Freedman; Nicholas J. Schork; Irving I. Gottesman
Mortality and Medical Comorbidity Among Patients With Serious Mental Illness
Brian J. Miller, M.D., M.P.H.; C. Bayard Paschall, III, Ph.D.; Dale P. Svendsen, M.D., M.S.
Cognitive Behavior Therapy for Schizophrenia
Douglas Turkington, M.D.; David Kingdon, M.D.; Peter J. Weiden, M.D.